Physician profile
Frederick Li
NPI 1013362391
$1,726.72
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $660 · 2021: $696 · 2022: $342 · 2023: $28.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $872.41 | 2020-2021 | |
| Nalu Medical, INC. | $441.63 | 2020-2022 | |
| Avanos Medical | $156.64 | 2021 | |
| Medtronic USA, INC. | $126.92 | 2020 | |
| Abbott Laboratories | $67.60 | 2020 | |
| Davol INC. | $28.51 | 2023 | |
| Collegium Pharmaceutical, INC. | $21.13 | 2021 | |
| Stimwave Technologies Incorporated | $11.88 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.